Ampersand Capital Partners is a middle-market private equity firm founded in 1988 that focuses exclusively. See sector focus and contact routes.
Ampersand Capital Partners is a middle-market private equity firm founded in 1988 that focuses exclusively on growth-oriented investments in the healthcare and life sciences sector, managing approximately $3 billion in assets. The firm invests in companies that support the life sciences ecosystem, specifically targeting the “picks and shovels” of healthcare such as laboratory products, lab services, contract manufacturing, pharma services, and specialty pharma. Ampersand primarily acts as the first institutional investor in founder-owned businesses within the lower to middle market, partnering with management teams to drive organic growth and operational improvements. The firm works through both minority and majority equity positions to build value alongside portfolio company leaders. Notable portfolio companies include Lab Products, Lab Services, Contract Manufacturing, Pharma Services, and Specialty Pharma entities within their focused sectors, though specific named company titles beyond these category descriptors are not explicitly listed in available public profiles. A distinctive point of view is their focus on mission-critical tools and services f
Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with comparable investors when building a target list.
Investors like Ampersand Capital Partners · Full investor directory · Investor access · Company funding database